NYSE
USANA Health Sciences, Inc. (USNA)
♥ 351 Thanks from members
USANA Health Sciences, Inc. (USNA) faces severe downward pressure following Q2 2026 earnings, driven by shrinking direct sales, a $29.1 million goodwill impairment charge for the Hiya venture brand, and downgraded 2026 guidance, leaving alternative data and market sentiment leaning heavily bearish.